Background-Vascular dysfunction in atherosclerosis and diabetes mellitus, as observed in the aging population of developed societies, is associated with vascular DNA damage and cell senescence. We hypothesized that cumulative DNA damage during aging contributes to vascular dysfunction. Methods and Results-In mice with genomic instability resulting from the defective nucleotide excision repair genes ERCC1 and XPD (Ercc1 d/Ϫ and Xpd TTD mice), we explored age-dependent vascular function compared with that in wild-type mice. Ercc1 d/Ϫ mice showed increased vascular cell senescence, accelerated development of vasodilator dysfunction, increased vascular stiffness, and elevated blood pressure at a very young age. The vasodilator dysfunction was due to decreased endothelial nitric oxide synthase levels and impaired smooth muscle cell function, which involved phosphodiesterase activity. Similar to Ercc1 d/Ϫ mice, age-related endothelium-dependent vasodilator dysfunction in Xpd TTD animals was increased. To investigate the implications for human vascular disease, we explored associations between single-nucleotide polymorphisms of selected nucleotide excision repair genes and arterial stiffness within the AortaGen Consortium and found a significant association of a single-nucleotide polymorphism (rs2029298) in the putative promoter region of DDB2 gene with carotid-femoral pulse wave velocity. Conclusions-Mice with genomic instability recapitulate age-dependent vascular dysfunction as observed in animal models and in humans but with an accelerated progression compared with wild-type mice. In addition, we found associations between variations in human DNA repair genes and markers for vascular stiffness, which is associated with aging. Our study supports the concept that genomic instability contributes importantly to the development of cardiovascular disease. (Circulation. 2012;126:468-478.)
diabetes mellitus, during which accumulation of damage increases the risk of developing vascular dysfunction and associated disease. 3 At the cellular level, this could be related to the increased production of reactive oxygen species (ROS) and a resulting increase in lipid oxidation or interference with cellular metabolism. This can directly affect vascular function and/or lead to apoptosis or cellular senescence, a state in which the cell remains in cell cycle arrest and has lost its optimal function. In the case of endothelial cells, this functional change results in a provasoconstrictor and proinflammatory phenotype. 4 
Clinical Perspective on p 478
Despite extensive research into oxidative stress-induced cellular damage and senescence, the main causative mechanism of aging and age-related CVD remains unknown. For instance, it is unclear why vasomotor function declines with aging, even in the absence of apparent risk factors. 5 Moreover, in the vast majority of epidemiological studies, aging remains the most significant risk factor for CVD, even after correction for classic cardiovascular risk factors. 3 The concept that unrepaired DNA damage has dramatic effects on the aging phenotype stems from multiple lines of evidence, including the fact that the majority of human progeroid syndromes are due to mutations in DNA damage repair and response genes. 6 One of the DNA repair systems that is very important in this regard is nucleotide excision repair (NER), which removes a wide class of helix-distorting DNA lesions induced by ultraviolet (UV) but also by numerous manmade or natural chemical compounds and ROS. The process of DNA damage removal consists of (1) DNA damage recognition by XPC for some lesions assisted by the UV-DDB1/2 (XPE) complex, (2) local unwinding of DNA provided by the multisubunit TFIIH complex, (3) damage verification by XPA, (4) excision of the damaged DNA section by endonucleases XPG and ERCC1/XPF, and (5) replacement of the excised DNA using the intact strand as template. Mutation of factors involved in NER can have severe consequences for human health as demonstrated by several human progeroid syndromes. Examples are the rare autosomal-recessive genetic disorders Cockayne syndrome, trichothiodystrophy, and the recently described XPF-ERCC1 syndrome. 7 For instance, trichothiodystrophy is caused by point mutations in the XPD, XPB, or TTDA gene, affecting DNA repair function and stability of the dual-functional NER/basal transcription initiation factor TFIIH. 8 This causes UV sensitivity and accelerated segmental aging symptoms, including early cessation of growth, cachexia, osteoporosis, progressive neurological abnormalities, and premature death. 9 Likewise, several mouse models with NER defects show a segmental premature aging phenotype in which the severity depends on the extent to which the DNA repair system is affected.
To investigate whether DNA damage plays a role in age-related vascular dysfunction, we studied vasomotor function and cellular senescence in 2 NER-defect mouse models, differing in type and severity of the DNA repair defect. In Ercc1 d/Ϫ animals, 1 allele of the NER-DNA crosslink repair (XLR) endonuclease ERCC1 is mutated, resulting in a truncated protein (lacking the C-terminal 7 amino acids), and the other allele is completely inactivated. 10 In Xpd TTD mice, the XPD helicase of the TFIIH core complex carries a homozygous R 722 W functional point mutation as found in a trichothiodystrophy patient. 11 The NER-XLR defect in the Ercc1 d/Ϫ animals is more severe, resulting in very early cessation of growth; very premature liver, kidney, bone marrow, and neurological aging phenotype; and a reduced lifespan of Ϸ5 to 6 months. The milder phenotype of Xpd TTD mice results in retarded growth, cachexia, an age-related osteoporosis, and a slightly reduced lifespan.
To investigate whether NER gene variations could have an impact on human vascular disease and in line with our murine phenotype, we performed genetic studies to examine the association of genetic variation in genes coding for proteins involved in NER with carotid-femoral pulse wave velocity (CFPWV). The associations between genetic variation in selected NER genes and the vascular phenotype were assessed within the framework of the AortaGen Consortium. 12 
Methods
For details of the experimental setup, see the online-only Data Supplement.
Animals
The animals used in experiments were 8-and 16-week-old Ercc1 d/Ϫ mice, their wild-type (WT) littermates of the same age, and 16-, 26-, and 52-week-old mice of the same background-F1 hybrid between FVB and C57Bl/6 and 26-and 52-week-old Xpd TTD mice and their WT controls in a C57Bl/6 background. All animal studies were approved by an independent animal ethics committee.
Isolation and Culture of Endothelial Cells
Endothelial cells were isolated from 16-week-old Ercc1 d/Ϫ mice and cultured under mouse lung endothelial cell medium under an atmosphere of normal air enriched with 5% CO 2 .
Senescence-Associated ␤-Galactosidase Staining
Senescence was determined by senescence-associated ␤-galactosidase staining (SA-␤-gal staining) at pH 6.0.
Quantitative Real-Time Polymerase Chain Reaction
Relative expression of cyclin-dependent kinase inhibitor 1A (p21) and tumor protein 53 (p53) genes was measured in thoracic aortas of 16-week-old Ercc1 d/Ϫ and WT mice.
Assessment of Blood Pressure and Vasodilator Function In Vivo
In vivo hind-leg vasodilator function was measured by laser Doppler perfusion imaging of reactive hyperemia after transient blood flow interruption in 8-week-old Ercc1 d/Ϫ and WT mice. Simultaneously, blood pressure was measured in conscious Ercc1 d/Ϫ mice and WT littermates with the tail cuff technique.
Organ Bath Experiments
The responses of aortic tissue from 8-and 16-week-old Ercc1 d/Ϫ mice and their 8-, 16-, 26-, and 52-week-old WT littermates, as well as 26-and 52-week-old Xpd TTD mice and their WT littermates, were measured in small wire myograph organ baths containing oxygenated Krebs-Henseleit buffer at 37°C. After preconstriction with 30 nmol/L U46619, relaxation concentration-response curves to acetylcholine were constructed, followed by an exposure to 100 mol/L sodium nitroprusside. N -nitro-L-arginine-methyl ester (L-NAME) 100 mol/L pretreatment was used to investigate the involvement of nitric oxide (NO). 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol; 100 mol/L) and N-acetyl-cysteine (NAC; 30 mol/L) were used as scavengers of ROS. Tetrahydrobiopterin (BH4; 100 mol/L) was used to prevent the uncoupling of endothelial NO synthase (eNOS). Vinpocetine (100 mol/L) was used to investigate phosphodiesterase activity.
Measurement of Mechanical Properties of the Vascular Wall
Carotid arteries were explanted from 16-week-old Ercc1 d/Ϫ and WT mice and mounted in the perfusion myograph. The vessel diameterpressure relationship was determined and stress-strain relationships were constructed. 13
Immunoprecipitation and Immunoblotting of eNOS
Aortas and hearts were used to investigate the levels of eNOS and the fraction of eNOS phosphorylated at position Tyr-657. Ser-1177 eNOS phosphorylation was investigated in lungs either at baseline or after 10 minutes of stimulation with 10 mol/L acetylcholine.
Statistical Methods of Animal Studies
Data are presented as meanϮSEM. Statistical analysis between the groups of single values was performed by 2-sided t test, 2-sided t test after log transformation of the data, Mann-Whitney U test, or 1-way ANOVA followed by the Bonferroni post hoc test when appropriate. To test the hypothesis that blood pressure would be increased in Ercc1 d/Ϫ animals, we used a 1-sided t test. Differences in doseresponse curves were tested by ANOVA for repeated measures (sphericity assumed). Differences were considered significant at PϽ0.05.
Human Studies
In accordance with the phenotype observed in mice, we investigated the association of single-nucleotide polymorphisms (SNPs) in NER components with CFPWV, a measure of vascular stiffness. CFPWV, a well-known marker of age-related vascular disease in humans, is strongly associated with increased risk for major CVD events. To investigate this association, we used the data from the AortaGen Consortium, which consists of 20 634 participants from 9 cohort studies. A detailed description of the AortaGen Consortium is provided in the online-only Data Supplement.
Statistical Methods of Human Studies
Genes coding for NER components that belong to the machinery that binds the DNA to either recognize or repair damage were selected. These were the following NER components: ERCC8 (CSA); ERCC6 (CSB); DDB1; DDB2 (XPE); ERCC1; GTF2H1 (p62); GTF2H3 (p34); GTF2H4 (p52); GTF2H5 (TTDA, TFB5); RAD23A (hHR23A); RAD23B (hHR23B); ERCC3 (XPB); XPC; ERCC2 (XPD); ERCC4 (XPF); and ERCC5 (XPG). To test for association with CFPWV, we selected the tag SNPs that cover the variation in the genes of interest Ϯ50 kb region around that were nonredundant at a linkage disequilibrium threshold of r 2 Ն0.7 using the Tagger program of Haploview. Our selection resulted in 310 SNPs. We decided a priori on a significance threshold of PϽ1.61ϫ10 Ϫ4 , which corresponds to the Bonferroni-adjusted P value for the number of tested SNPs.
Results

Vascular Cell Aging in Ercc1 d/Ϫ Mice
SA-␤-gal staining of aortas from 16-week-old Ercc1 d/Ϫ mice compared with their WT littermates showed that, macroscopically, senescence staining clearly dominated in aortas from Ercc1 d/Ϫ ( Figure 1A) . Microscopically, stained cells were detected in both the endothelium and media of Ercc1 d/Ϫ aortas. The quantity and visibility of senescent cells allowed reliable counting in the media, showing a marked increase in Ercc1 d/Ϫ animals ( Figure 1B) . Similarly, RNA levels of the genes composing DNA damage-related CDK inhibition p21 (Cdkn1a) and p53 (Trp53) were increased in the aorta of To further investigate the effect of defective NER on proliferative senescence in endothelial cells, we measured the percentage of SA-␤-gal-positive cells after 20 days in culture. The levels of SA-␤-gal-positive endothelial cells in the lung were on average 10.3 times higher in cultures from Ercc1 d/Ϫ compared with WT mice ( Figure 1E and 1F ).
On the basis of the robust proliferation of freshly cultured lung endothelial cells, we decided to test endothelialdependent angiogenic outgrowth potential in aortic explants of 16-week-old Ercc1 d/Ϫ and WT mice. No significant difference in outgrowth was observed ( Figure I 
In Vivo Vascular Function of NER-Defective and WT Mice
To determine possible functional changes in the vasculature, we assessed vasodilator function in response to reactive hyperemia in the hind limbs of 8-week-old WT (Figure 2A ) and Ercc1 d/Ϫ mice ( Figure 2B ). In 8-week-old Ercc1 d/Ϫ animals, we observed a decreased reactive hyperemia ( Figure 2C and 2D ). In addition, we observed a significant increase in systolic pressure, mean arterial pressure, and pulse pressure in Ercc1 d/Ϫ mice ( Figure  2E -2H). Diastolic blood pressure tended to increase, albeit without statistical significance ( Figure 2G ).
Age-Dependent Change of Ex Vivo Vascular Function in WT and NER-Defective Mice
To reveal the mechanisms of vasodilator dysfunction in Ercc1 d/Ϫ mice and to address the question of age dependency, we compared vasodilator function in 8-and 16-week-old mice. At both ages, mice show signs of progeria without obvious deterioration in general health. Ercc1 d/Ϫ animals showed progressive reduction of acetylcholine-induced aortic relaxation at these ages ( Figure 3A ). Sodium nitroprusside responses were reduced in 16-week-old Ercc1 d/Ϫ mice and tended to be decreased in 8-week-old Ercc1 d/Ϫ mice ( Figure  3B ). To estimate the contribution of the endothelium to vasodilator dysfunction, acetylcholine-induced relaxations were corrected for sodium nitroprusside responses, revealing that the endothelial contribution to the response to acetylcholine was reduced in Ercc1 d/Ϫ mice compared with WT mice at both ages ( Figure 3C ).
DNA repair-competent WT animals 16, 26, and 52 weeks of age showed a much slower age-dependent reduction in acetylcholine responses than Ercc1 d/Ϫ , becoming statistically significant after 52 weeks ( Figure 3D ). Endotheliumindependent responses to sodium nitroprusside did not change in WT mice ( Figure 3E ).
To determine whether a slower onset of progeria could delay the onset of vascular dysfunction, we assessed vascular function in the NER-impaired Xpd TTD mouse that displays a milder phenotype. Vasodilator responses to acetylcholine in U46619-precontracted aortic rings were significantly reduced in 52-week-old Xpd TTD mice compared with those at 26 weeks and more markedly than in WT littermates ( Figure 3F ). The noticeable, modest difference between 52-week-old Xpd TTD and WT animals did not reach significance. Endothelial-independent responses to sodium nitroprusside were equal ( Figure 3G) .
Pretreatment with the eNOS inhibitor L-NAME abolished all acetylcholine-induced relaxations in all animals (data not shown), indicating that acetylcholine responses depended entirely on eNOS/NO.
Mechanisms of Endothelial Vasodilator Dysfunction in NER-Defective Mice
In aortas from 16-week-old Ercc1 d/Ϫ mice, eNOS levels were reduced by Ϸ67% compared with WT ( Figure 4A ). Phosphorylation of the tyrosine residue at position 657 (pTyr657-eNOS) inhibits eNOS, 14 and this tyrosine phosphorylation tended to be increased in Ercc1 d/Ϫ hearts ( Figure 4B ). eNOS-activating phosphorylation of the serine residue at position 1177 (pSer1177-eNOS) was comparable in explanted WT and Ercc1 d/Ϫ lungs at baseline, but 10 mol/L acetylcholine increased pSer1177-eNOS only in WT mice ( Figure 4E ).
Uncoupling of eNOS results in a switch from NO to ROS production. It can be a consequence of the decreased availability of the essential cofactor BH4, and its reconstitution can restore NO production. 15 BH4 had no effect on the acetylcholine-induced relaxation of aortic rings from WT mice but restored that of rings from Ercc1 d/Ϫ mice ( Figure  5A ). BH4 also increased endothelium-independent sodium nitroprusside responses ( Figure 5B ) in Ercc1 d/Ϫ .
ROS coming from various sources can scavenge NO, thereby leading to vasodilator dysfunction that can be rescued by ROS scavengers. Whereas tempol was without effect ( Figure IIA and IIB in the online-only Data Supplement), NAC caused a modest and significant improvement of the acetylcholine and sodium nitroprusside responses in Ercc1 d/Ϫ aortas ( Figure 5C and 5D ). After correction for sodium nitroprusside responses, acetylcholine responses were not changed by BH4 or NAC ( Figure 5E and 5F) . Therefore, the BH4-and NAC-induced improvement in relaxations most likely represents improved vascular smooth muscle cell (VSMC) sensitivity.
Mechanisms of VSMC Vasodilator Dysfunction in NER-Defective Mice
The phosphodiesterase inhibitor vinpocetine improved sodium nitroprusside responses in Ercc1 d/Ϫ mice ( Figure 6 ). The phosphodiesterase 5-specific inhibitor sildenafil had similar effects (data not shown; nϭ5). The responses to an activator of protein kinase G were identical in Ercc1 d/Ϫ mice and WT littermates (nϭ9 per group; logarithm of concentra- 
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tion needed to reach 50% dilation, Ϫ5.268Ϯ0.2353 versus Ϫ5.569Ϯ0.1957, respectively).
Mechanical Properties of Conductive Vessels in Ercc1 d/Ϫ
Under similar perfusion pressure increments, differential increases in the vessel lumen were observed in Ercc1 d/Ϫ compared with WT mice ( Figure 7A ). Recalculation of measured values demonstrated a significantly lower strain, indicating lower elasticity, in Ercc1 d/Ϫ mice under comparable stress as WT ( Figure 7B and 7C ). Morphometric analysis of microscopic sections shows that although the vascular wall thickness of Ercc1 d/Ϫ is significantly lower, the wall-tolumen ratio was equal ( Figure III in the online-only Data Supplement).
Human Studies
Previous human studies indicate that NER-component SNPs influence the risk of developing cancer, 16 suggesting that these SNPs modulate NER function. Ercc1 d/Ϫ mice showed an increased vascular stiffness. We hypothesized that genetic variation in the NER components might also influence vascular stiffness in humans. Increased vascular stiffness is an important feature of human vascular aging, represented by the variable CFPWV. Therefore, we studied the effect of SNPs in NER components that, like ERCC1 and XPD, belong to the machinery that binds the DNA to either recognize or repair damage on variation of CFPWV in the cohorts from the AortaGen Consortium. The AortaGen Consortium used a sex-specific standardized regression residual for 1000/CFPWV that was adjusted for age, age squared, height, and weight for meta-analysis. Genome-wide association analyses were conducted with the use of an additive gene-dose model. The results for the association of the genetic variants in the NER components with CFPWV in humans are presented in the Table. The allele dose effect is expressed as standard deviations of inverse CFPWV per coded allele. After Bonferroni correction for multiple testing, 1 locus reached an association with CFPWV at the threshold of Pϭ1.61ϫ10 Ϫ4 , namely SNP rs2029298 (␤, Ϫ0.05; SE, 0.01; Pϭ1.04ϫ10 Ϫ4 ). The closest gene to this SNP is DDB2 (XPE). Another SNP in this region, rs3781619, located within the DDB2 (XPE) gene, showed a suggestive association with the CFPWV measure (␤, Ϫ0.03; SE, 0.02; Pϭ3.80ϫ10 Ϫ2 ). In addition, we found suggestive associations for 8 other SNPs located within or near ERCC5 (XPG), ERCC6 (CSB), GTF2H3, GTF2H1, and ERCC2 (XPD). To summarize, DDB2 (XPE) was the most important gene associated with CFPWV.
Discussion
The present study shows that mice with an increased susceptibility to DNA damage resulting from a defect in NER as in Xpd TTD and NER and XLR as in Ercc1 d/Ϫ display an increased number of senescent vascular cells, an increased susceptibility of endothelial cells to become senescent, and accelerated worsening of vasodilator function during aging. The worsening of vasodilator function involves both endothelial cell and VSMC dysfunction. Furthermore, Ercc1 d/Ϫ mice display increased vascular stiffness, systolic blood pressure, and pulse pressure and reduced reactive hyperemia, which are typical features of vascular aging in humans. In addition, genetic association studies from the AortaGen Consortium suggest that SNPs in NER genes coding for components that participate in DNA recognition and repair contribute to vascular stiffness, as measured by CFPWV, in humans. These results suggest that genomic instability is involved in the development of vascular aging and warrant further investigations into the involvement of the DNA repair systems in age-related CVD.
The involvement of DNA damage and repair in age-related vascular disease is also apparent from previous clinical studies showing that senescent cells and oxidative DNA damage are present in atherosclerotic plaques, 17, 18 the beneficial effects of statins on DNA repair, 19 the increased levels of 8-hydroxy-2,9-deoxyguanosine in urine of hypertensive subjects, 20 and genome-wide association studies that report an association between SNPs in the 9p21 locus with risk for coronary artery disease, intracranial aneurysm, and type 2 diabetes mellitus. 21 These SNPs, which are located in the ANRIL noncoding RNA, lie in the vicinity of the INK4A genes that code for the cyclin-dependent kinase inhibitors p15/CDKN2B, p16/CDKN2A, and p14/ARF, which may affect the induction of cellular senescence in response to DNA damage. 22 Deletion of ANRIL in mice reduces Cdkn2a and Cdkn2b expression and increases cultured smooth muscle cell proliferation. 23 Vascular function has not been assessed in these mice. No previous studies have examined vascular senescence parallel to vascular function, but the studies cited here [17] [18] [19] support our hypothesis that DNA damage and cellular senescence contribute to the pathogenesis of agerelated CVD.
Ercc1 d/Ϫ mice exhibited reduced reactive hyperemia, suggesting vasodilator dysfunction in resistance vasculature. Increased peripheral resistance may lead to increased mean arterial pressure, which was observed in Ercc1 d/Ϫ mice. Because systolic blood pressure also increased, we suspected reduced compliance of conduit vessels. The observation that aortic dilator function was decreased in Ercc1 d/Ϫ and Xpd TTD supports this concept. However, Ercc1 d/Ϫ dilator function seems to depend on both VSMC and endothelial function, whereas Xpd TTD showed no impaired VSMC relaxation. Naturally aging mice also showed endothelial dysfunction without VSMC impairment. Thus, the observed VSMC dysfunction in Ercc1 d/Ϫ might represent an extreme aging phenotype, as might be expected from a combined defect of NER and XLR. Although the senescence marker prelamin A is found in aortic VSMCs of aged humans outside atherosclerotic plaques, 24 the role of VSMC senescence in human vasodilator function remains unclear, whereas a role in atherosclerosis has been proposed. 25 In contrast, the role of endothelial (progenitor) cell senescence has been amply addressed. 4, 18, 26 We explored the role of eNOS in vasodilator dysfunction and found that aortic NO function and eNOS levels are decreased in Ercc1 d/Ϫ mice. This is in agreement with previous observations in 26-to 28-month-old mice and with a diminished NO release and eNOS expression in cultured senescent endothelial cells and atherosclerotic plaque samples. 18, [27] [28] [29] [30] [31] Our pharmacological studies with BH4, tempol, and NAC show that ROS production resulting from eNOS uncoupling does not play a major role in the observed aortic endothelial dysfunction. At most, ROS modestly affected VSMC function. Interestingly, BH4 and NAC improved vasodilator function to a similar extent. This might suggest a similar action of both compounds, which would be in line with ROS scavenging properties of BH4. 32 Our observation that BH4 improved mainly VSMC instead of endothelial cell vasodilator function in aorta is in sharp contrast to the observation that the BH4 precursor sepiapterin improved dilations to acetylcholine but not to NaNO 2 in mesenteric arteries of 24-month-old mice 33 and warrants exploration of vasodilator mechanisms in resistance vessels from our mice.
Exploration of the endothelium-independent vasodilator dysfunction revealed that phosphodiesterase inhibition almost completely rescued VSMC vasodilator function. This strongly suggests the existence of a relative phosphodiesterase overactivity in Ercc1 d/Ϫ mice. Interestingly, the substrate of several phosphodiesterase enzymes, cGMP, also regulates VSMC proliferation 34 and extracellular matrix composition. 35 Therefore, long-term changes in cGMP levels could lead to vascular changes, including increased stiffness and a higher number of senescent cells. A prolonged increase in phosphodiesterase activity and reduction in NO production could thus lead to an increased vascular stiffness, as supported by the increased vascular stiffness, despite an increased sensitivity to NO, in eNOS knockout mice. 36 In Ercc1 d/Ϫ mice, the reduced sensitivity to NO will contribute even further to reduced cGMP levels.
Our human genetic study intended to explore whether there is a possible relationship between genetic variants in NER genes and risk for increased vascular stiffness, a typical marker for human vascular aging that was recapitulated in the Ercc1 d/Ϫ mice. Besides finding 1 SNP, rs2029298, upstream of the start codon of DDB2 (XPE) that passed the Bonferronicorrected significance level, we found suggestive associations of SNPs in or close to ERCC5, ERCC6, GTF2H3, GTF2H1, and XPD for CFPWV. The finding that CFPWV is significantly associated with DDB2 is compelling because CFPWV is the human equivalent of the mouse variables for vascular stiffness that were measured and is negatively associated with vasodilator function in aging mice 31 and humans. 37 DDB2 encodes the smaller subunit of a heterodimeric DNA binding protein with high affinity to UV-damaged DNA (UV-DDB) and has been studied in both rodents and humans. XPE is a component of NER, and its activity is not tied to transcription, but it acts in the whole genome. The role of XPE is to identify UV-induced lesions, ie, cyclobutane pyrimidine dimers and polycyclic aromatic hydrocarbon adducts. 38 The function of the upstream region in which the SNP for DDB2 was found has not been characterized, although the gene in humans has been shown to be under control of p53, the guardian of the genome, and to be inducible after genotoxic stress. Hence, DDB2 (XPE) may at least in part control global genome NER.
As is usual for common genetic variants, the effect sizes were small. The effect size of our top SNP, rs2029298, is Ϫ0.05Ϯ0.01 SD per allele after correction for age, age squared, sex, height, and weight. Extrapolation of this value of Ϫ0.05 SD per allele to an absolute age value for an individual with the use of CFPWV-age association graphs is difficult because these relations are not linear. Moreover, the impact of the SNP will depend on other risk factors that are present. It is possible, however, to compare the relative contribution of the risk allele of SNP rs2029298 with others found in genome-wide association studies. In the AortaGen Consortium study, the locus, found in a BCL11B gene desert, that was most strongly associated with CFPWV had an effect size of Ϫ0.075Ϯ0.012 SD per allele. Clearly, the effect size of the DDB2 SNP found in the present study is in a comparable range.
More detailed sequencing might pinpoint genetic variants with stronger associations. This is an important consideration in view of the evolutionary pressure against genetic variations that severely impair the function of DNA repair systems. Severe DNA repair dysfunctions are often lethal or lead to infertility, which makes them more likely to be present only as minor alleles. Furthermore, the involvement of a DNA repair defect in vascular damage might depend strongly on the presence of factors that induce DNA damage. Nonetheless, increased PWV is prominently present in Hutchinson-Gilford progeria, a very rare syndrome caused by genomic instability resulting from mutation of the LMNA gene, which is featured by premature cardiovascular death. 12, 39 
Conclusions
We explored the possibility of whether the reduced efficiency of 2 DNA repair pathways, NER and interstrand crosslink repair, contributes to vascular aging in mice. We observed functional changes in the vasculature (worsened vasodilator function and increased vascular stiffness) and hypertension, which are reminiscent of changes in aging humans and animals. We also found an association between SNPs of genes that encode for relevant NER components and increased vascular stiffness. From these observations, we conclude that DNA repair capacity is associated with accelerated vascular aging in mice and that there may be implications for risk stratification in humans with respect to age-dependent CVD. Whether this relates to oxidative stress, classic risk factors, and/or local damage or even extends beyond these limits will be a central question in studies to come.
